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Summary statement: A strategy to decipher which tail-anchored proteins do (as opposed to can 


























 JCS Advance Online Article. Posted on 10 June 2019
Abstract 
 
The TRC pathway targets tail-anchored (TA) proteins to the membrane of the endoplasmic 
reticulum (ER). While many TA-proteins are known to be able to use this pathway, it is essential 
for the targeting of only a few. Here, we uncover a large number of TA-proteins that engage 
with TRC40 when other targeting machineries are fully operational. We use a dominant 
negative, ATPase-impaired, mutant of TRC40 in which aspartate 74 was substituted by 
glutamate to trap TA-proteins in the cytoplasm. Manipulation of TRC40’s hydrophobic TA-
binding groove reduces interaction with most but not all substrates suggesting that co-
purification may also reflect interactions unrelated to precursor protein targeting. We confirm 
known TRC40 substrates and identify many additional TA-proteins interacting with TRC40. 
Using the trap approach in combination with quantitative mass spectrometry, we show that 
Golgi-resident TA-proteins such as the golgins golgin-84, CASP, and giantin as well as the 
vesicle-associated membrane-protein-associated proteins VAPA and VAPB interact with 
TRC40. Thus, our results provide new avenues to tackle the essential role of TRC40 in 

























The presence of membrane proteins customizes biological membranes to suit their 
respective functions beyond the formation of a permeability barrier. Membrane proteins enable 
transmembrane transport, modify the lipid environment, or mediate membrane contacts. This 
is true for the plasma membrane as well as for the many intracellular membranes enclosing 
subcellular compartments. The integration of a protein into a membrane-forming lipid bilayer 
is a feat of nature since protein biogenesis occurs in the aqueous phase. Investigation of the 
cellular machineries that enable the integration of proteins into membranes is as much a 
classical area as a current focus of molecular cell biology.  
Reductionist approaches afford tremendous insights into the fundamentals of membrane 
integration of proteins. In fact, in-vitro reconstitution (Kutay et al., 1995; Stefanovic and Hegde, 
2007) and the theoretical, physicochemical analysis of transmembrane segments (TMS) (von 
Heijne, 2007) have enabled the field to formulate detailed hypotheses about rules that govern 
membrane integration of proteins. In parallel, systematic strategies have uncovered several 
different protein complexes and pathways involved in membrane targeting at large (Aviram et 
al., 2016; Nguyen et al., 2018; Schuldiner et al., 2008; Shurtleff et al., 2018). These discoveries 
raise questions with regard to redundancy (which may be in place to achieve robustness), tissue 
specificity (which may optimize the physiological function of specialized cell types), and 
hierarchy of different membrane protein targeting pathways. Investigation of different cell 
types by physiologically-minded in-vivo approaches has revealed that some substrates are 
particularly sensitive to the loss of a specific pathway (Casson et al., 2017; Norlin et al., 2016; 
Rivera-Monroy et al., 2016).  
An interesting example is provided by the topologically defined class of tail-anchored 
(TA) proteins that comprise one hydrophobic TMS at the C-terminus that anchors the protein 
in the membrane. The cytoplasmic N-terminus endows such proteins with their diverse 
functions, e.g. in vesicular traffic (most SNARE proteins are TA-proteins) whereas the luminal 
C-terminus does not exceed 40 amino acids (Borgese et al., 2003; Kutay et al., 1993). TA-
proteins occur on all membranes facing the cytoplasm. The TA-proteins found in the contiguous 
secretory pathway, plasma membrane, and endo-lysosomal system are thought to be integrated 
into the membrane of the endoplasmic reticulum (ER) before they reach their respective locales 
by vesicular traffic (Borgese et al., 2007; Jäntti et al., 1994; Kutay et al., 1995; Linstedt et al., 























The yeast GET or mammalian TRC pathway has been identified as a highly conserved 
cellular pathway capable of targeting the class of TA-proteins to the ER (Favaloro et al., 2008; 
Mariappan et al., 2010; Schuldiner et al., 2008; Stefanovic and Hegde, 2007). A plethora of 
complementary data from systematic genetic analyses in yeast (Jonikas et al., 2009; Schuldiner 
et al., 2008), in-vitro biochemical dissection (Bozkurt et al., 2009; Favaloro et al., 2008; 
Favaloro et al., 2010; Stefanovic and Hegde, 2007), and numerous crystal structures (Bozkurt 
et al., 2009; Gristick et al., 2014; Hu et al., 2009; Kubota et al., 2012; Mateja et al., 2009; Mateja 
et al., 2015; Simpson et al., 2010; Stefer et al., 2011; Yamagata et al., 2010) have helped 
generate the current model of TRC pathway function. Yet, it has become equally clear that in 
vivo the TA-proteins destined for the ER have several additional targeting options, such as the 
signal recognition particle (SRP) system (Abell et al., 2004; Abell et al., 2007; Casson et al., 
2017), the SRP-independent targeting (SND) components (Aviram et al., 2016; Haßdenteufel 
et al., 2017), or the ER membrane complex (EMC) (Guna et al., 2018; Shurtleff et al., 2018). 
Hence, it is necessary to carefully distinguish which TA-proteins can use the TRC pathway 
from the precursors for which it is essential. While the existing tools such as in-vitro assays and 
knockout cells or organisms have begun to provide answers to these questions (Casson et al., 
2017; Figueiredo Costa et al., 2018; Guna et al., 2018; Haßdenteufel et al., 2017; Lin et al., 
2016; Norlin et al., 2016; Norlin et al., 2018; Pfaff et al., 2016; Rivera-Monroy et al., 2016; 
Vogl et al., 2016), an approach is still lacking that would reveal which TA-proteins do in fact 
use the TRC pathway when all targeting options are operational, i.e. without the compensatory 
effects often provoked by knockout strategies.  
Here, we present a novel strategy to tackle this problem. Based on the ATPase cycle of 
TRC40, we designed and characterized a dominant negative “trap” mutant of TRC40, which 
accumulates TRC40-interacting precursor TA-proteins in the cytoplasm. This approach helped 
us to confirm known substrates of the pathway, to distinguish precursors that can but do not 
have to use TRC40-dependent membrane integration, and to test a large spectrum of 
endogenously expressed TA-proteins for their capacity to interact with TRC40 in the intact 
cellular environment. In addition, unbiased analysis of the TRC40 trap mutant’s interactome by 
label-free quantitative mass spectrometry identified more than ten TA-proteins interacting with 
TRC40. Among these newly identified and subsequently verified TA-proteins are golgins such 
as golgin-84, CASP, and giantin. Golgins are central to the organization and functionality of 
the Golgi apparatus (Gillingham and Munro, 2016). Given the crucial role of giantin in the 
posttranslational modification of secretory proteins by glycosylation (Lan et al., 2016; McGee 























essentiality of the TRC pathway in mammals. At the same time, our data suggest that the 
observed co-purification of TA-proteins with TRC40 may partially reflect a molecular 
interaction unrelated to precursor protein targeting. Hence, our analysis motivates future focus 
on the chaperone function of proteins homologous to TRC40 and its yeast counterpart Get3 





Steady-state levels of TA-proteins upon combined WRB and TRC40 depletion report on TRC 
pathway substrates with limited fidelity 
Cellular quality control promotes the degradation of membrane protein precursors that 
mislocalize because their preferred targeting pathway is not operational (reviewed in Guna and 
Hegde, 2018). This consequence of mistargeting has been exploited to interpret the reduced 
steady-state levels of a TA-protein upon knockout or siRNA-mediated knockdown of TRC 
pathway components as evidence for the targeting of the respective substrate via TRC40 
(Casson et al., 2017; Haßdenteufel et al., 2017; Norlin et al., 2016; Rivera-Monroy et al., 2016). 
In combination with in-vitro insertion assays, which answer the question whether a given 
substrate can target to the membrane of the ER via a TRC40 and WRB/CAML-dependent route, 
the results of this approach have been useful to identify substrates of the pathway, for which it 
is obligatory, such as syntaxins Stx5 and Stx6 as well as emerin (EMD) (Norlin et al., 2016; 
Pfaff et al., 2016; Rivera-Monroy et al., 2016).  
Using this strategy in HeLa cells, we assessed the steady-state levels of TA-proteins that 
were implied by in-vitro assays as TRC pathway dependent substrates but not definitively and 
systematically tested as substrates in intact cells (Fig. 1). Substantial knockdown of TRC40 and 
WRB was achieved (Fig. 1A,B) and the combined transfection with siRNAs directed against 
TRC40 and WRB resulted in a robust reduction of the TRC40 ATPase and both TRC40-
receptor proteins, WRB and CAML. In effect, this manipulation leads to a knockout of the 
membrane targeting phase of the TRC40 cycle, in line with results obtained from the analysis 
of a Wrb-knockout mouse (Rivera-Monroy et al., 2016). As a positive control, we recapitulated 
TA-protein substrates known to depend on the TRC pathway in vivo such as Stx5, Stx6 and 
EMD, which showed reduced steady-state levels but also aberrant subcellular localization when 























Indeed, the steady-state levels of all three substrates in the membrane fraction were strongly 
reduced (Fig. 1C,D) upon down-regulation of TRC40 and WRB.  
Next, we tested two TA-proteins, Sec61, Sec22b, and Stx8 (Fig. 1C,D), for which good 
in-vitro evidence exists that they – or their highly conserved yeast orthologues – require the 
mammalian TRC or yeast GET pathway (Jonikas et al., 2009; Rivera-Monroy et al., 2016; 
Schuldiner et al., 2008; Stefanovic and Hegde, 2007; Stefer et al., 2011; Yamagata et al., 2010). 
Yet, the in-vivo reliance of these proteins on the pathway was reported to be variable or they 
turned out to be TRC40- and WRB-independent (Casson et al., 2017; Norlin et al., 2016; 
Rivera-Monroy et al., 2016). In HeLa cells, Sec61, Sec22b, and Stx8 displayed reduced 
steady-state levels in the membrane fraction upon the combined down-regulation of TRC40 and 
WRB (Fig. 1C,D). Interestingly, previous work reported proper localization of Sec61 in 
TRC40- or WRB-knockout cells or mouse tissue (Casson et al., 2017; Norlin et al., 2016; Rivera-
Monroy et al., 2016) indicating that assays of subcellular localization may report less sensitively 
on an involvement of the TRC pathway than assessments of steady-state protein levels.  
As a negative control for the assay, we included the TA-protein PTP1B, that is able to 
insert spontaneously into liposomes (Brambillasca et al., 2006), and squalene synthase (SQS) 
recently shown to be TRC40-independent (Guna et al., 2018; Shurtleff et al., 2018). For PTP1B 
no significant changes were observed upon silencing TRC40 or both WRB and TRC40 although 
the scatter of the observed signal does not exclude subtle effects (Fig. 1C,D). SQS steady-state 
levels increased upon combined knock-down of TRC40 and WRB. The molecular mechanisms 
behind the steady-state levels of a protein may be complex. On the one hand, compensatory 
changes in other targeting pathways (Haßdenteufel et al., 2017) may hide TRC pathway 
dependence. On the other hand, effects downstream of bona-fide targeting substrates such as 
Stx5 may suggest targeting dependence of a complex partner whose stability is affected by the 
targeting client. Indeed, Sec22b is a SNARE partner protein of Stx5 (Hay et al., 1997) and its 
steady-state levels may be indirectly affected by the combined down-regulation of WRB and 
TRC40. For PTP1B and SQS, our results are consistent with the notion that they do not require 
the TRC pathway for proper targeting. 
To avoid conclusions based on TA-protein steady-state levels alone, we developed a 
complementary approach to tackle the question whether a substrate displaying in-vitro 
dependence and in-vivo or in-cellulo independence of TRC40 does use the pathway when it is 
available. To more directly probe the propensity of a TA-protein precursor to be targeted by the 























AAA ATPase, and GTPase fields that have used dominant negative forms of the respective 
enzyme to trap transiently interacting substrates (Chen et al., 2014; Flynn et al., 2003; Jessop 
et al., 2009; Klebe et al., 1995). Based on the current model of the TRC40 ATPase cycle and 
the associated conformations of the protein (Fig. 2A), we set out to address the flux through the 
TRC pathway by a substrate-trapping approach. 
 
 
 Expression of ATPase-impaired TRC40D74E alters the subcellular localization of TA-proteins 
TRC40 and its yeast orthologue Get3 are members of the SIMIBI family of NTPases, which 
also includes the SRP (Bange and Sinning, 2013). In contrast to the GTPase activity of SRP, 
Get3 is an ATPase that undergoes large conformational changes in response to ATP binding 
and hydrolysis (Fig. 2A). Hence, several residues involved in ATP-binding or hydrolysis have 
been targeted to experimentally manipulate Get3. Several studies used Get3G30R (Johnson et al., 
2013; Schuldiner et al., 2005; Shen et al., 2003; Suloway et al., 2009; Wang et al., 2011b), 
which targets the P-loop or Walker A motif and is predicted to be deficient in nucleotide-
binding (Saraste et al., 1990). Another extensively used mutant is Get3D57N, which targets the 
conserved Switch I ATPase domain. This mutation impairs the ATPase-activity of Get3 (Chio 
et al., 2017; Mateja et al., 2009; Stefer et al., 2011; Wang et al., 2011a) rather than abolishing 
nucleotide-binding. Based on the effects of changing the orthologous D45 in the Switch I 
domain of the bacterial homolog ArsA (Zhou and Rosen, 1999), we created Get3D57E (Powis et 
al., 2013), demonstrated its strongly impaired ATPase activity, and showed its inability to 
substitute for wild-type Get3 in yeast although the protein was well-expressed. The current 
model of the Get3 ATPase cycle and by extension TRC40 (Fig. 2A) predicts that a form of the 
protein that can bind but not hydrolyze ATP may capture but not release TA-protein substrates 
(Chio et al., 2017; Mariappan et al., 2011; Stefer et al., 2011). Our previous results with yeast 
Get3D57E (Powis et al., 2013), specifically the co-localization of Get3D57E-GFP and a TA-protein 
substrate in intracellular foci, are consistent with the idea that TA-protein precursors may be 
trapped by this mutant in cells. To make use of this tool in the mammalian system where many 
more TA-proteins exist (Kalbfleisch et al., 2007), we constructed and characterized the 
homologous TRC40D74E mutant. 
Originally, small TA-proteins such as Sec61 (Stefanovic and Hegde, 2007) or Ramp4 
(Favaloro et al., 2008) were used as model substrates to identify the mammalian TRC pathway 























protein Stx5 is the best-characterized TRC40 substrate that critically depends on the presence 
of the pathway in vivo (Casson et al., 2017; Norlin et al., 2016; Norlin et al., 2018; Rivera-
Monroy et al., 2016). Likewise, yeast syntaxin 5 (Sed5) requires Get3 for proper localization 
and targeting (Jonikas et al., 2009; Powis et al., 2013; Schuldiner et al., 2008; Voth et al., 2014). 
Therefore, we used Stx5 as a substrate to assess the impact of TRC40D74E on TA-protein 
insertion in an in-vitro insertion assay using a C-terminally opsin-tagged variant of the TA-
protein substrate Stx5 (Fig. 2B). The opsin tag is an N-glycosylation tag that corresponds to 13 
amino acids of bovine opsin. It becomes glycosylated on the luminal side once the protein is 
inserted into the ER. Thereby it enables to monitor the ER-insertion of the protein (Abell et al., 
2007; Borgese et al., 2001; Favaloro et al., 2010; Honsho et al., 1998; Kutay et al., 1995; Masaki 
et al., 1996; Pedrazzini et al., 2000; Schuldiner et al., 2008; Stefanovic and Hegde, 2007). 
Reticulocyte lysate was immuno-depleted of TRC40, which strongly reduced glycosylation and 
hence insertion of Stx5 (Fig. 2B). Re-expressing either wild type TRC40 or TRC40D74E in the 
immuno-depleted lysate revealed that TRC40D74E was not capable of mediating the insertion of 
Stx5 (Fig. 2B). Instead, it was able to reduce the small amount of glycosylated and hence 
inserted Stx5 observed in the immuno-depleted sample. 
In mammalian cells and in yeast, impairing the TRC/GET pathway leads to a loss of 
Stx5/Sed5 from the Golgi apparatus (Casson et al., 2017; Norlin et al., 2016; Rivera-Monroy et 
al., 2016; Schuldiner et al., 2008). Therefore, we used the subcellular localization of 
endogenous Stx5, determined by indirect immunofluorescence, as a readout to evaluate the 
effects of TRC40D74E over-expression (Fig. 2C). We transfected HeLa cells with c-Myc-tagged 
TRC40 constructs and performed double-labeling immunofluorescence staining for Stx5 and 
c-Myc-TRC40. Upon transfection with the TRC40D74E mutant, Stx5 changed its subcellular 
localization showing a diffuse, apparently cytoplasmic staining instead of the Golgi-staining 
that reflects proper membrane targeting and subsequent sorting of Stx5. Over-expression of 
TRC40wt showed a partially cytoplasmic staining for Stx5 (Fig. 2C) in line with the idea that 
the conformation stabilized by TRC40D74E reflects a step of the normal TRC40 cycle that can 
also be populated more by raising the TRC40 levels. Alternatively, over-expression of TRC40 
may create a large pool of the ATPase free of TA-protein substrate. This form of TRC40 may 
titrate out the binding sites on the receptor required for proper Stx5 targeting. Using the 
TRC40D74E-based assay, we revisited the TA-protein PTP1B, whose steady-state levels were 
not significantly affected by silencing the TRC pathway (Fig. 1C,D), and observed no obvious 























To corroborate the trapping function of the Asp 74 to Glu mutant, we tested another 
presumably ATPase-deficient mutant, D74N, which was previously reported to constitutively 
bind TA-proteins in the background of Get3 (Mateja et al., 2009; Mateja et al., 2015; Stefer et 
al., 2011). Over-expression of TRC40D74N resulted in the same change of Stx5 subcellular 
localization (Fig. S1) that we had observed in the presence of TRC40D74E (Fig. 2C). This 
observation is in line with a recent report that TRC40D74N failed to restore proper distribution 
of Stx5 in dorsal pancreas explants (Norlin et al., 2018). We tested another bona-fide TRC40-
substrate, EMD (Pfaff et al., 2016; Rivera-Monroy et al., 2016), and observed a diffusely 
distributed population when staining the TRC40D74E-transfected cells for endogenous EMD 
(Fig. S2). Together, these results strengthen the notion that over-expression of TRC40 mutants, 
in which ATP-binding capacity is preserved but ATPase activity is impaired, may divert the 
TA-protein substrate from its subcellular destination, the Golgi membrane in the case of Stx5 
or the inner nuclear membrane in the case of EMD.  
 
Over-expression of TRC40D74E causes cytoplasmic accumulation of TA-proteins 
In order to analyse whether the diffuse staining pattern observed for Stx5 and EMD in 
TRC40D74E-transfected cells (Figs 2C, S2) reflected localization to the cytoplasm, we semi-
permeabilized cells with digitonin before immunofluorescence staining (Fig. 3A). Digitonin 
preferentially permeabilizes the plasma membrane leaving the rest of the cell membranes intact 
(Plutner et al., 1992; Wilson et al., 1995). In untransfected cells, Stx5 was observed in its typical 
Golgi staining pattern (compare Fig. S3) upon digitonin semi-permeabilization but – as 
expected for cytoplasmic components – the diffuse Stx5 signal observed upon TRC40D74E-
transfection was washed out (Fig. 3B). This experiment indicates that Stx5 accumulates in the 
cytoplasm upon over-expression of TRC40D74E.  
To further corroborate this conclusion, we developed a stable cell line (Flp-In T-REx-
293) with an opsin-tagged Stx5 at the C-terminus under the control of a tetracycline-inducible 
promoter. In order to biochemically investigate whether Stx5 is accumulated in the cytosol, as 
indicated by its cytoplasmic localization observed by immunofluorescence, we transfected the 
Stx5-opsin (Stx5-op) stable cell line with c-Myc-tagged TRC40 constructs before induction of 
the opsin-tagged substrate to create a pulse of Stx5 precursors. Next, we performed subcellular 
fractionation and analyzed the different fractions by Western blot. Stx5-op steady-state levels 
were higher in the cytosolic fraction of the cells transfected with TRC40D74E than in the those 
transfected with the empty vector (Fig. 3C), corroborating the observations obtained by 























membrane fraction where we observed two (Fig. 3C). The single band observed in the cytosol 
is consistent with the interpretation that an unglycosylated biogenetic precursor was trapped. 
Furthermore, analysis of the membrane fraction suggested less Stx5-op was glycosylated and 
hence inserted into the membrane in the presence of over-expressed TRC40D74E as compared 
to TRC40wt. These findings raise the possibility that TRC40D74E interacts with Stx5 in the 
cytoplasm and acts as a trap mutant impeding its handover to the TRC receptor to enable 
membrane-insertion.  
Therefore, we tested whether TRC40D74E and endogenous Stx5 physically interact. We 
transfected HEK293 cells with c-Myc-TRC40 constructs and immuno-precipitated c-Myc-
TRC40 from the cytosol in the absence of detergent, which was then probed for co-precipitating 
endogenous Stx5 (Fig. 3D). We also probed for Sec61 to test a candidate substrate that 
certainly can target via the TRC pathway as demonstrated by in-vitro assays (Favaloro et al., 
2008; Favaloro et al., 2010; Stefanovic and Hegde, 2007), was affected in its steady-state levels 
upon TRC pathway silencing (Fig. 1C,D), but does not depend on it for proper subcellular 
localization (Casson et al., 2017; Rivera-Monroy et al., 2016). To corroborate our interpretation 
that TRC40D74E acts as a substrate trap, we introduced two additional mutations into the plasmid 
encoding the protein. These have been shown to reduce the affinity of the TA-binding groove 
– formed by the TRC40 dimer – for the TMS of the TA-protein (Mateja et al., 2009; Shao et 
al., 2017). The resulting c-Myc-TRC40D74E/L190D/I193D poorly co-precipitated Stx5 and Sec61 
(Fig. 3D). Consistent with the notion that the diffuse Stx5 staining pattern in TRC40D74E-
transfected cells reflects a cytoplasmic population in complex with TRC40, the Golgi 
localization of Stx5 was partially rescued in the presence of the triple mutant 
TRC40D74E/L190D/I193D (Fig. S3). The effect of restoring the proper subcellular localization by 
combining the D74E mutation with the additional two mutations, which reduce the binding 
affinity of the TRC40 to the TMSs of TA-proteins, was very clear for EMD (Fig. S2). Thus, 
the cytosolic interaction, and hence the diffuse staining pattern observed for substrates in the 
presence of TRC40D74E, correlated with an intact TA-binding groove consistent with our 
rationale to stabilize the TA-protein interacting form of TRC40. It should, however, be noted 
that much less is currently known about the molecular details of how Get3-like chaperones 
interact with their clients (Farkas et al., 2019; Voth et al., 2014). Hence, we cannot exclude that 
some of the effects of over-expressing TRC40D74E may not directly relate to membrane 
























 Characterization of TA-protein interactome of TRC40D74E 
 Based on our characterization of TRC40D74E as a substrate trapping mutant, we applied 
this tool in two independent, complementary strategies to map the TRC40 client spectrum. On 
the one hand, we used a large panel of antibodies (Table S1) to test the presence of TA-proteins 
in the c-Myc-TRC40D74E immunoprecipitates (Fig. S4). As the silencing approach (Figs 1, S7), 
this approach is limited by the quality of the antibodies available. On the other hand, we 
conducted an unbiased mass spectrometry-based approach and transfected HEK293 cells with 
c-Myc-TRC40D74E and the corresponding triple mutant TRC40D74E/L190D/I193D that reduces the 
affinity of the TMS binding groove for TA-protein substrates (Fig. 3D). After subcellular 
fractionation and anti-c-Myc immuno-precipitation from the cytosol in the absence of 
detergent, the eluates were analyzed by unbiased label-free mass spectrometry. Qualitatively, 
2329 proteins out of 3135 detected proteins were identified in either eluate, including 18 TA-
proteins (Table S2). Since 95 TA-proteins were detected in whole-cell lysates of HEK293 cells 
(Geiger et al., 2012), we identified 20% of all robustly expressed TA-proteins in the cytosol of 
the transfected HEK293 cells. The eluates were then quantitatively compared by SWATH 
(Sequential Window Acquisition of All Theoretical Fragment Ion Spectra) (Lambert et al., 
2013) mass spectrometry (Table S3 lists the peptides used for quantification). We corroborated 
the results corroborated by Western Blot analysis of individual c-Myc-TRC40 proteins and the 
amounts of co-immuno-precipitated Stx5 (Figs S4, S5). Both approaches unequivocally 
confirmed the results obtained in Figs 2 and 3, i.e. the trapping of Stx5 by TRC40D74E, and 
hence the suitability of the approach to identify TA-proteins that do interact with TRC40. 
The results of the SWATH mass spectrometry approach are depicted in a volcano plot 
of the enrichment with the single or triple TRC40 mutant plotted against the statistical 
significance of the result (Fig. 4). All components of the mammalian pretargeting complex, i.e. 
SGTA, BAG6, UBL4A, and TRC35 (magenta dots in Fig. 4) were detected in the eluates. 
Except for a possible modest enrichment of TRC35 with c-Myc-TRC40D74E/L190D/I193D these 
proteins showed no preference for either form of TRC40. With the exception of the golgin 
giantin, all TA-proteins (blue dots in Fig. 4, Table S2) were either present in equal amounts or 
enriched with c-Myc-TRC40D74E. The positive control protein Stx5 was enriched about two-
fold and right at the significance limit (P < 0.05). Focusing on the six TA-proteins that were 
enriched similarly or more strongly than Stx5 (Fig. 4, Table S2), i.e. UBE2J1, LAP2B, VAMP7, 
EMD, and VAPB (DCAKD was not studied further due to the unavailability of a specific 























(Table 1, Fig. S4A). As expected for EMD based on the literature (Pfaff et al., 2016) and the 
results presented here (Figs 1, S2), all five TA-proteins were confirmed as TRC40-interactors 
contacting the TA-binding groove (Fig. S4A).  
The candidate-based approach using antibodies affords a much higher sensitivity for 
detecting TA-proteins in the TRC40-immunoprecipitaes. Using this strategy, we were able to 
substantially extend the number of tested TA-proteins. In addition to Stx5, Sec61, and the five 
TA-proteins tested after identification by the SWATH mass spectrometry approach (EMD, 
VAPB, VAMP7, LAP2B, UBE2J1), we were able to obtain meaningful data regarding an 
additional 22 TA-proteins (Table 1, Fig. S4B,C). Importantly, this approach also revealed 7 
TA-proteins that were not trapped by TRC40D74E although they were robustly detected in whole 
cell lysates (Fig. S4C). The total list of 30 probed TA-proteins is a valuable resource when 
corroborating or refuting rules that determine TRC40-dependence of a client.  
We confirmed the capacity to create a diffuse, presumably cytoplasmic pool due to 
trapping by TRC40D74E for two additional syntaxins (Fig. S6). Stx6 is a SNARE protein 
involved in Golgi trafficking (Bock et al., 1996; Cheng et al., 2010) and has previously been 
implicated as a bona-fide TRC40 substrate with manipulation of the pathway in vivo affecting 
its steady-state levels and localization (Norlin et al., 2016; Rivera-Monroy et al., 2016). Stx8 is 
a SNARE protein localized at endosomes (Kasai et al., 2008; Prekeris et al., 1999; 
Subramaniam et al., 2000). Interestingly, its steady-state levels were not affected in the liver or 
the ventricle of the Wrb knockout mouse and its subcellular localization indicated robust 
membrane targeting (Rivera-Monroy et al., 2016). Although the two syntaxins reacted 
differently to the loss of the TRC pathway in these mouse tissues, they both enriched with 
TRC40D74E (Fig. S4B, Table 1). In line with this observation, we observed a partially diffuse 
staining pattern for endogenous Stx6 (Fig. S6A) and Stx8 (Fig. S6B) upon over-expression of 
the TRC40 trap. Many of the antibodies used for Western blotting were not suited for indirect 
immunofluorescence, which is why we limited ourselves to confirming the appearance of a 
presumably cytoplasmic pool for selected TA-proteins (Stx5, Stx6, Stx8, EMD). In all cases, 
physical interaction with TRC40D74E was predictive of the aberrant subcellular localization that 
is consistent with substrate trapping in the cytoplasm. 
One TA-protein – the coiled-coil forming golgin giantin – was substantially enriched 
with the triple mutant c-Myc-TRC40D74E/L190D/I193D (Fig. 4). This behavior may suggest an 
interaction with TRC40 that does not depend on the TA-binding groove. Using an antibody 
against endogenous giantin, that worked well in indirect immunostaining but not Western 























mutant (Fig. 5A) and observed a diffuse and reduced Golgi staining pattern when either 
TRC40D74E or the triple mutant were expressed. Hence, giantin behaved similarly to Stx5 but, 
unlike it, did not react to the manipulation of the TA-binding groove. We hypothesized that the 
unusual presence of a histidine in the TMS of giantin (Fig. 5B) could explain the effect of the 
triple mutant on the subcellular localization of the protein. The exchange of two hydrophobic 
residues by aspartates creates a negative patch in the center of the TA-binding groove. 
Inspection of the TMS of other TA-golgins, i.e. golgin-84 and CASP (Gillingham and Munro, 
2016), revealed a histidine in the same position (Fig. 5B). We tested whether they interacted 
with TRC40D74E or the triple mutant by immuno-precipitation (Fig. 5C,D). Indeed, golgin-84 
and CASP interacted with both TRC40 variants or even preferred the triple mutant in the case 
of the golgin CASP.  
To test whether this preference involved a charge interaction between the histidine and 
the negatively charged TMS binding groove, we introduced positively charged side chains and 
created the triple mutant c-Myc-TRC40D74E/L190K/I193K, which should make binding of an TMS 
containing a histidine energetically unfavorable. In the case of golgin-84 but not CASP, this 
reduced the interaction substantially with respect to co-purification with TRC40D74E or the 
negatively charged triple mutant (Fig. 5C,D). With respect to golgin-84, our result confirms a 
report by Casson et al. (2017) who also described an interaction of the protein with TRC40 
(without testing its dependence TMS-binding groove) but observed no effect on its steady-state 
localization in a TRC40 knock-out cell line (Casson et al., 2017). In summary, we conclude 
from our data that the TA-golgins fall into the class of substrates that can be targeted by the 
TRC pathway but do not absolutely require it for correct subcellular localization (Casson et al., 
2017). Interestingly, we observed strong reductions in the steady-state levels of both CASP and 
golgin-84 upon combined silencing of WRB and TRC40 (Fig. S7) further corroborating the 
notion that the TRC pathway is highly relevant to their turnover. While our results plausibly 
support a model where TRC40 can target the TA-protein golgins they also highlight that a 
proportion of the observed TRC40-co-purifying pool may reflect an interaction in a functional 
context distinct from precursor targeting. Given the important roles of Stx5, Stx6, and the 
golgins in Golgi morphology and function more work will be required to determine how direct 
and indirect effects combine to result in the observed reduction at the steady-state.  
Figure 6 summarizes the data for the whole TA-protein panel that we investigated in 
experiments probing the enrichment by the TRC40D74E mutant (Fig. 6A based on data in Figs 
3, 4, S4, S5 and Table 1) or TA-protein steady-state levels upon combined TRC40 and WRB 























respective TMS. A dotted line indicates the hydrophobicity score of the Sec61 TMS 
previously proposed as the dividing line that determines TRC40-dependence of a TA-protein 
precursor (Guna et al., 2018). We chose the GRAVY score (Kyte and Doolittle, 1982) instead 
of the transmembrane tendency score (Zhao and London, 2006) to describe the properties of 
the TMSs. The main difference between the two scores lies in the weight allocated to aromatic 
residues, which frequently occur in membrane proteins but are less hydrophobic than aliphatic 
side chains. However, no systematic differences were observed when correlating our 
experimental results with the series of TMS scores determined by one or the other method.  
While both experimental parameters generally correlate well with TMS hydrophobicity, 
i.e. most TA-proteins with a TMS more hydrophobic than Sec61 do interact with TRC40 and 
respond to the manipulation of the TRC pathway, the dividing line defines a region of TMS 
hydrophobicity where it is impossible to predict whether a TA-protein is affected by the trap or 
the silencing. In fact, our data provide examples of proteins that interacted but whose steady-
state levels were not affected (Stx18, GOSR2) or vice versa (Fis1, MOSPD2). Furthermore, we 
found TA-proteins with TMSs in a hydrophobicity range identical to bona-fide substrates 
(SYNE1, SYNE3, ZFPL1; red dots in Fig. 6A based on Fig. S4C) that we were unable to trap 
using TRC40D74E although their steady-state levels were strongly affected when the TRC 
pathway was not operational. In conclusion and after careful consideration of the caveats 
associated with either experimental strategy, the data presented in Fig. 6 allow a reassessment 
of the properties of a TA-protein relevant to its interaction with TRC40, which may represent 






In vitro approaches have been extensively used to study the functional interaction of 
TRC40 with different TA-proteins (Favaloro et al., 2008; Favaloro et al., 2010; Johnson et al., 
2012; Leznicki et al., 2010; Leznicki et al., 2011; Mariappan et al., 2011; Rabu et al., 2008; 
Stefanovic and Hegde, 2007). The hydrophobicity of the TMS has been considered a key factor 
for organelle targeting (Borgese et al., 2001; Borgese et al., 2003; Borgese et al., 2007; 
Bulbarelli et al., 2002) as well as for discriminating between different targeting pathways to the 
same subcellular compartment (Costello et al., 2017b; Guna and Hegde, 2018; Guna et al., 























pathways raises the question which pathway is in charge of the biogenesis of a given TA-protein 
when all pathways are operational.  
In order to address this problem, we developed an ATPase-impaired, dominant-negative 
mutant of TRC40 that is able to trap TA-proteins in the cytoplasm. For the first time, it has been 
possible to co-immunoprecipitate TRC40, preserving the interactions with endogenous TA-
proteins, without the use of crosslinkers. This tool enables us to identify the in-vivo TA-protein 
interactome of TRC40 in human cells (Fig. 6A). We used both, candidate testing as well as 
unbiased identification of the most enriched targeting clients. We identified novel TRC40 
targets, such as VAPA and VAPB, which are involved in membrane contact sites and lipid 
exchange between organelles (Costello et al., 2017a; Dong et al., 2016; Hua et al., 2017; 
Manford et al., 2012; Rocha et al., 2009), and the subclass of coiled-coil forming golgins, such 
as giantin, golgin-84, and CASP, that are tethered to the medial Golgi by a C-terminal TMS. 
Although the interpretation of the TRC40 interaction that we observed in terms of biogenesis 
is consistent with all experimental evidence and the current model of TRC40-dependent 
targeting we cannot exclude that the trapped intermediates may also reflect an intermediate of 
another TRC40-related pathway, i.e. in the context of cellular quality control or proteostasis. In 
fact, the interaction of TRC40D74E with the TA-protein golgin CASP did not depend on an intact 
hydrophobic groove thought to accommodate the TMS of TA-proteins (Fig. 5 C,D) suggesting 
that TRC40 may recognize another aspect of this golgin.    
In line with the proposed cut-off for TRC40 interaction (Guna et al., 2018), we have 
trapped one TA-protein with a TMS hydrophobicity score substantially lower than that of 
Sec61, i.e. Stx18 (1.62 versus 2.05) based on the GRAVY score to determine TMS 
hydrophobicity (Kyte and Doolittle, 1982). However, using transmembrane tendency (Zhao 
and London, 2006) the TMS of Sec61 and Stx18 score similarly (21.45 versus 21.62).  
Generally, this does not mean that transmembrane tendency is a better predictor of the ability 
of a TA-protein to interact with TRC40 since the UBE2J1 and GOSR2 TMS score substantially 
lower than Sec61 using transmembrane tendency but were nevertheless trapped (this was 
better predicted by the GRAVY score where they show a higher hydrophobicity than Sec61, 
Fig. 6A). As expected based on the hydrophobicity of the TMS by either score, we exclude 
PTP1B as a TRC40 client: Only marginal effects on its steady-state levels were observed upon 
combined WRB and TRC40 silencing and it did not co-immunoprecipitate with the trapping 
mutant of TRC40 although it was well detected in the cell lysates. This is consistent with the 
finding that PTP1B was able to spontaneously insert into liposomes (Brambillasca et al., 2006). 























mutant (Fig. S4B,C). However, their steady-state levels reacted differently to the combined 
silencing of TRC40 and WRB: This manipulation strongly reduced the steady-state levels of 
Fis1 but not BNIP3L (Fig. S7). Taken together, these results are consistent with the notion that 
mitochondrial TA-proteins do not use the TRC pathway (Figueiredo Costa et al., 2018). Hence, 
the effect on Fis1 steady-state levels may relate to another function of TRC40.  
We identified three TA-proteins, SYNE1, SYNE3, and ZFPL1 that were not trapped by 
TRC40D74E (Figs S4C, 6A) despite a TMS hydrophobicity score that would have predicted an 
interaction with TRC40 during biogenesis. We cannot exclude that such a failure to be trapped 
may reflect a low amount of TA-protein precursor present in the cell although  ZFPL1 was 
abundantly detected in HeLa and HEK293 cells (Cho et al., 2018; Geiger et al., 2012). 
Generally, we found no indication that copy numbers or half-life – as available from systematic 
studies on protein turnover in HeLa cells (Cambridge et al., 2011; Cho et al., 2018) – correlated 
with the propensity of a TA-protein to be trapped by TRC40D74E. For example, TA-proteins 
identified by SWATH mass spectrometry with high confidence ranged from 140 million 
molecules per cell and a half-life of 47 hours (EMD) to 3 million and 20 hours (Stx5) or even 
only 800 thousand molecules per cell (UBE2J1). In fact, based on the available data (Cambridge 
et al., 2011; Cho et al., 2018) VAPB (80 million molecules per cell and 42 h) and FIS1 (56 
million and 40 h) or GOSR2 (10 million, 29 h) and PTP1B (6 million, 31 h) are pairs of TA-
proteins of very similar abundance and half-life that perfectly underscore TMS hydrophobicity 
as the dominant parameter as a prediction for TRC40 recruitment in live cells. 
The TRC40 triple mutant we generated disturbs the hydrophobic pocket of TRC40. 
Consistent with the expectation that this manipulation would reduce the affinity of TRC40D74E 
for TA-proteins we observed a strong reduction in co-immunoprecipitation of most TA-protein 
substrates (Figs 3D, 4, S4, S5). However, the two TA-golgins golgin-84 and CASP were clear 
exceptions as they co-purified equally or even more strongly with the triple mutant compared 
to TRC40D74E. We attribute this to a central histidine within the TMS of the TA-golgins that 
may be able to interact electrostatically with the mutant, now negatively charged, binding 
pocket of TRC40. Consistent with this notion, golgin-84 interacted substantially less with a 
charged-inverted triple mutant TRC40D74E/L190K/I193K. In contrast, CASP co-purified more 
extensively with either triple mutant compared to TRC40D74E. This suggests that the interaction 
between TRC40 and CASP is independent of the TA-binding groove and may instead be based 
























 The yeast GET pathway is encoded by non-essential genes (Schuldiner et al., 2008) 
despite the fact that a strongly Get3-dependent substrate, i.e. Sed5 (yeast Stx5), is encoded by 
an essential gene (Giaever et al., 2002). The phenotypes of get deletion mutants become 
apparent under stress conditions such as heat or oxidative stress (Kiktev et al., 2012; Metz et 
al., 2006). In contrast, the TRC pathway is essential in mammalian cells (Mukhopadhyay et al., 
2006; Tran et al., 2003). The identification of novel TA-protein substrates presented here 
provides new avenues into understanding why this system is so important in multicellular 
organisms: VAPA, encoded by a gene essential for early embryonic development in the mouse 
(McCune et al., 2017), and VAPB are important for membrane contacts and lipid homeostasis 
(Costello et al., 2017a; De Vos et al., 2012; Hua et al., 2017). The TA-protein subgroup of 
golgins plays a major role in organizing vesicular traffic between the different cisternae of the 
Golgi (reviewed in Munro, 2011). They are key determinants of the posttranslational 
modification of secretory proteins in the Golgi. In particular, giantin is required for the proper 
localization and activity of Golgi-resident glycosyltransferases (Stevenson et al., 2017). 
Together with SNARE proteins – active in the Golgi and the endosomal pathway – the client 
spectrum of the TRC pathway suggests a scope that will not only affect the trafficking, but also 
the posttranslational modification of secretory proteins, and the homeostasis of the 
endomembrane system at large.  
Our findings offer a satisfying synthesis of information on TA-protein targeting 
obtained by different approaches (Fig. 7). Even though redundant with other targeting options, 
the TRC pathway represents a robust route to the ER and accommodates a large client spectrum 
(Fig. 7 group 1). The precise flux may differ from cell type to cell type: While Stx8 steady-state 
levels were not affected in a Wrb-knockout mouse model (Rivera-Monroy et al., 2016) the 
protein was reduced in HeLa cells upon silencing of TRC40 and WRB (Figs 1, 6B). For some 
clients the TRC pathway may be nothing but a back-up option (group 2). In several cases TRC 
pathway manipulation affected the steady-state levels of proteins (Fig. 7 group 3) but no 
interaction with the TRC40 trap was observed. The explanation may differ for the different TA-
proteins in this group, ranging from indirect effects to a very low rate of biogenesis. Some of 
the TA-proteins in this group feature a TMS hydrophobicity score well compatible with 
TRC40-dependent targeting (the nesprins SYNE1 and SYNE3 and ZFPL1) and it will be 
























 An important dimension that is rarely studied in the context of targeting experiments is 
the functional outcome of targeting by different pathways for individual proteins. After 
biogenesis and to fulfill their cellular functions, the golgins, Stx5, and the VAPs all undergo 
many diverse and often reversible protein-protein interactions resulting in coiled-coils, SNARE 
bundles, or dynamic tethers between two membranes. Since a chaperone holdase activity of 
Get3 has been reported (Voth et al., 2014), it may be worth considering that the TRC pathway 
could aid its clients beyond targeting by chaperoning their cytoplasmic domains. In the case of 
Stx5, we have provided some evidence that critical determinants of TRC40-dependence may 
map to the N-terminal domain of the TA-protein (Rivera-Monroy et al., 2016). So far, all 
analyses demonstrating proper targeting of a TA-protein in the absence of the TRC pathway 
conclude that targeting was covered by another pathway, because no effect on the steady-state 
levels or localization of the protein was observed. However, the functionality of TA-proteins 
that can be targeted by TRC40 but do not strictly require it has never been explored, namely 
with respect to the protein-protein interactions of their N-terminal domains or their dynamic 
behavior within the membrane. We propose that a full understanding of TA-protein targeting 
will eventually include mechanisms that cater to the function of specific TA-proteins in addition 
to ensuring that they are brought to the right membrane during the initial phase of biogenesis. 
 
 
Materials and Methods 
Plasmids and constructs 
All constructs were obtained using standard molecular biology methods and all sequences were 
verified by Sanger sequencing (GATC Biotech, Konstanz, Baden-Württemberg, Germany).  
pcDNA3.1(-)_c-Myc-TRC40 was obtained after subcloning it from MBP-TEV-TRC40/ZZ-
EMD-opsin, previously described (Favaloro et al., 2010), into a pcDNA3.1(-) (Invitrogen, 
Carlsbad, CA, USA) by using overlap extension PCR. Primers for mutagenesis of TRC40 
contained a sequence for making it insensitive to the small interference RNA (Catalog#: s1675; 
Ambion, Austin, TX, USA) that was described before (Pfaff et al., 2016; Rivera-Monroy et al., 
2016). First, one PCR using a forward primer containing an N-terminal c-Myc-tag for TRC40 
and a restriction site for XhoI 
(ATACTACTCGAGATGGAGCAGAAACTCATCTCTGAAGAGGATCTGATGGCGGCA
GGGGTGGCC) and the reverse primer 























be mutagenized. Second, another PCR using a forward primer 
(TCCCCCTTTATTTCCCAAATGTGCAACATGCTGGGCCTGG), overlapping the 
sequence of the aforementioned reverse, and a reverse primer targeting the C-terminus of 
TRC40 and containing a restriction site for BamHI 
(ATACTAGGATCCCTACTGGGCACTGGGGGGCT) was performed. A third PCR using the 
products of the first two PCRs was performed. The PCR-product was cloned into pcDNA3.1(-
) using BamHI and XhoI. 
The pcDNA3.1(-)_c-Myc-TRC40 mutants were obtained by site-directed mutagenesis using 
the following primers: D74E forward primer 
(GTGTTCTGATCATCTCCACAGAGCCAGCACACAACATCTCAG)  and reverse primer 
(CTGAGATGTTGTGTGCTGGCTCTGTGGAGATGATCAGAACAC); D74N forward 
primer (GTGTTCTGATCATCTCCACAAACCCAGCACACAACATCTCAG) and reverse 
primer (CTGAGATGTTGTGTGCTGGGTTTGTGGAGATGATCAGAACAC); I193D 
forward primer (CCTGGGCCGGCTTATGCAGGACAAGAACCAGATCTCC) and reverse 
primer (GGAGATCTGGTTCTTGTCCTGCATAAGCCGGCCCAGG); L190D/I193D 
forward primer (GGAGCGGGGCCTGGGCCGGGACATGCAGGACAAGAACCAG) and 
reverse primer (CTGGTTCTTGTCCTGCATGTCCCGGCCCAGGCCCCGCTCC); 
L190K/I193K forward primer 
(CGTGGAGCGGGGCCTGGGCCGGAAGATGCAGAAGAAGAACCAGATCTCCCCCTT
TATTTCC) and reverse primer 
(GGAAATAAAGGGGGAGATCTGGTTCTTCTTCTGCATCTTCCGGCCCAGGCCCCGC
TCCACG). 
The plasmid pGEM3Z-Stx5-opsin for the in vitro transcription and translation assays was 
described before (Rivera-Monroy et al., 2016). For pET23b_c-Myc-TRC40 constructs 
pcDNA3.1(-)_c-Myc-TRC40 plasmids were digested with NheI and HindIII and the inserts 
were ligated into a pET23b. 
 
Cell culture 
HeLa P4 cells (Charneau et al., 1994) were obtained from the NIH AIDS Reagent Program. 
HeLa P4 and T-REx 293 Stx5-op cells were grown in DMEM (Gibco, Carlsbad, CA, USA) 
supplemented with 2 mM L-glutamine (Gibco) and 10% (v/v) FBS (Biochrom, Berlin, 
Germany) in a 37°C incubator at 5% CO2. They were tested for contamination by Mycoplasma 























 T-REx 293 Stx5-opsin cell line generation  
Flp-In T-REx 293 cells (Invitrogen) were cultured with DMEM supplemented with 10 μg/mL 
blasticidin. pOG44 and pcDNA5/FRT/TO_Stx5-opsin plasmids, described previously, were 
co-transfected. Two days after transfection, cells were selected by incubating with DMEM++ 
supplemented with 15 μg/mL blasticidin and 200 μg/mL hygromycin B for two weeks until 
obtaining positive clones. The expression of Stx5-op from the stable transfectants was tested 
by Western blot. For inducing the expression of Stx5-op, 1 μg/mL tetracycline was added into 
the medium and the cells were incubated at 37°C for 6 h.  
 
Cell transfection and knockdown 
HeLa P4 or T-REx 293 cells were seeded to be 60-80% the day of transfection. Lipofectamine 
2000 (Invitrogen) was used for transfections. Cell were incubated for 6 h and then harvested 48 
h after Lipofectamine 2000 transfection.  
Small interference RNA (siRNA) was used for the knockdown of TRC40 and WRB. Specific 
RNA oligos against WRB and TRC40 were described previously (Rivera-Monroy et al., 2016) 
and luciferase siRNA (sense: CGUACGCGGAAUACUUCGA, antisense: 
UCGAAGUAUUCCGCGUACG, Sigma-Aldrich) was used as control. For the knockdown, 
cells were transfected twice at 48 h interval using Lipofectamine RNAiMAX (Invitrogen). Cells 
were incubated for 24 h with the RNAiMAX-siRNA solution and harvested 48 h after the last 
transfection. 
 
Cell fractionation  
The lysis of the cells was performed with a dounce homogenizer and the lysate was centrifuged 
for 1 h at 180,000 g at 4°C for sedimenting the membranes. The pellet was resuspended and 
centrifuged again at 180,000 g for 20 min at 4°C. The cytosolic and membrane fractions 
underwent protein extraction with solubilization buffer, as previously described (Kline et al., 
2009). Finally, cytosolic and membrane fractions were subjected to TCA precipitation, and 
























 Indirect immunofluorescence 
Cells were grown in coverslips, fixed with 4% (w/v) paraformaldehyde (PFA) in PBS for 15 
min and then permeabilized with 0.05% SDS in PBS/0.3% Triton X-100 for 10 min at room 
temperature. Cells were blocked in 10% FBS in PBS for 30 min and incubated with primary 
antibodies diluted in 5% FBS in PBS overnight at 4°C. Incubation with Alexa Fluor secondary 
antibodies (Invitrogen) was performed for 60 min at room temperature. The samples were 
mounted with Mowiol-DAPI. The list of antibodies can be found in Table S1. Cells were 
analyzed using an Axiovert 200M fluorescence microscope with a 63× Plan-Neofluar 1.3 NA 
water-corrected objective and appropriate filter settings. Images were acquired by using a LSM 
510-META confocal laser scanning microscope (Zeiss, Jena, Thuringia, Germany). For 
confocal imaging a UV laser (405 nm) at 25 mW, a tunable Argon laser (488 nm) at 30 mW, 
HeNe laser line (543 nm) at 1 mW, HeNe laser lines (633 nm) at 3 mW were used for excitation. 
Emission filters: 450/60 nm, 518/25 nm, 588/56 nm, long-pass (LP) 650 nm respectively. The 
analysis of the images was performed with ImageJ 1.51w software (US National Institutes of 
Health, Bethesda, USA) (Schneider et al., 2012). 
 
Digitonin semipermeabilization  
HeLa P4 cells on coverslips were semi-permeabilized with a solution of 0.007% of digitonin in 
transport buffer (20 mM HEPES, 110 mM KOAc, 2 mM Mg(OAc)2, 1 mM EGTA, pH 7.3, 2 
mM DTT, 0.1 mM PMSF and 1 µg/ml each of leupeptin, pepstatin and aprotinin) for 5 minutes 
on ice in living cells prior to fixation. Control cells were permeabilized with 0.3% Triton X-
100/0.05% SDS in PBS after PFA fixation.  
 
TRC40 co-immunoprecipitation 
Cells expressing empty vector (EV), wt, D74E, D74E/L190D/I193D, D74E/L190K/I193K c-
Myc-TRC40 variants from 15 cm dishes were polytron-homogenized in 500 μL IP buffer (50 
mM HEPES, 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, pH 7.4). 2.5 mg of total lysate was 
diluted with IP buffer to 1.2 mL and centrifuged at 180,000 g for 1 h to obtain the cytosolic 
fraction. 
200 μL of cytosol were used as input. The rest, approximately 1 mL, was incubated for 2.5 h in 
a rotation wheel with 50 μL Pierce Anti-c-Myc agarose resin (Thermo Scientific, Waltham, 























600 μL columns and washed 3 times (2 min each) prior elution with 50 μL 1x loading buffer 
plus 100 mM DTT.  
 
Mass spectrometric analysis 
Samples were reconstituted in 1× NuPAGE LDS Sample Buffer (Invitrogen) and applied to 4-
12 % NuPAGE Novex Bis-Tris Minigels (Invitrogen). For quantitation, samples were run 1 cm 
into the gel for purification. For generation of a spectral library, pooled aliquots of biological 
replicates for each sample were run half-distance through the gel. Gels were stained with 
Coomassie Blue for visualization purposes, and the library lanes cut into 12 equidistant slices 
regardless of staining. Quantitation samples were processed as a single slice. After washing, 
gel slices were reduced with dithiothreitol (DTT), alkylated with 2-iodoacetamide and digested 
with trypsin overnight. The resulting peptide mixtures were then extracted, dried in a SpeedVac, 
reconstituted in 2% acetonitrile/0.1% formic acid/ (v:v) and prepared for nanoLC-MS/MS as 
described previously (Atanassov and Urlaub, 2013). All samples were spiked with a synthetic 
peptide standard used for retention time alignment (iRT Standard, Biognosys, Schlieren, 
Switzerland).  
Protein digests were analyzed on a nanoﬂow chromatography system (Eksigent nanoLC425) 
hyphenated to a hybrid triple quadrupole-TOF mass spectrometer (TripleTOF 5600+) equipped 
with a Nanospray III ion source (Ionspray Voltage 2400 V, Interface Heater Temperature 
150°C, Sheath Gas Setting 12) and controlled by Analyst TF 1.7.1 software build 1163 (all 
Sciex, Framingham, MA, USA). In brief, peptides were dissolved in loading buffer (2% 
acetonitrile, 0.1% formic acid in water) to a concentration of 0.3 µg/µl. For each analysis 1.5 
µg of digested protein were enriched on a precolumn (0.18 mm ID x 20 mm, Symmetry C18, 5 
µm; Waters, Milford/MA, USA) and separated on an analytical RP-C18 column (0.075 mm ID 
x 250 mm, HSS T3, 1.8 µm, Waters) using a 55 min linear gradient of 5-35 % acetonitrile/0.1% 
formic acid (v:v) at 300 nl min-1. 
Qualitative LC/MS/MS analysis was performed using a Top25 data-dependent acquisition 
method with an MS survey scan of m/z 350–1250 accumulated for 350 ms at a resolution of 
30,000 full width at half maximum (FWHM). MS/MS scans of m/z 180–1600 were accumulated 
for 100 ms at a resolution of 17,500 FWHM and a precursor isolation width of 0.7 FWHM, 
resulting in a total cycle time of 2.9 s. Precursors above a threshold MS intensity of 125 cps 
with charge states 2+, 3+, and 4+ were selected for MS/MS, the dynamic exclusion time was 























manufacturer’s default rolling collision energy settings. One technical replicate per gel slice 
was analyzed to construct a spectral library. 
For quantitative SWATH analysis, MS/MS data were acquired using 65 variable size windows 
(Zhang et al., 2015) across the 400-1,050 m/z range. Fragments were produced using rolling 
collision energy settings for charge state 2+, and fragments acquired over an m/z range of 350–
1400 for 40 ms per segment. Including a 100 ms survey scan this resulted in an overall cycle 
time of 2.75 s. 3x3 replicates were acquired for each biological state for quantitation purposes. 
Protein identiﬁcation was achieved using ProteinPilot Software version 5.0 build 4769 (AB 
Sciex) at “thorough” settings. A total of 541,419 MS/MS spectra from the combined qualitative 
analyses were searched against the UniProtKB human reference proteome (revision 04-2018, 
93,609 entries) augmented with a set of 52 known common laboratory contaminants to identify 
3,135 proteins at a False Discovery Rate (FDR) of 1%. 
Spectral library generation and SWATH peak extraction were achieved in PeakView Software 
version 2.1 build 11041 (Sciex) using the SWATH quantitation microApp version 2.0 build 
2003. Following retention time correction using the iRT standard, peak areas were extracted 
using information from the MS/MS library at an FDR of 1% (Lambert et al., 2013). The 
resulting peak areas were then summed to peptide and ﬁnally to 2,329 protein area values across 
all injections, which were used for further statistical analysis.  
 
Western-blot 
Antibodies were diluted in blocking buffer: 5% milk in PBS plus 0.1% Tween-20. The list of 
primary and secondary antibodies can be found in Table S1. The opsin monoclonal antibody 
(R2-15) was obtained from the laboratory of Bernhard Dobberstein from the University of 
Heidelberg and it was a kind gift from Paul A. Hargrave from the University of Florida that 
was described before (Adamus et al., 1991). TRC40 #4 and Sec61β antibodies were a kind gift 
from the laboratory of Bernhard Dobberstein. BAG6 antibody was a kind gift from the 
laboratory of Stephen High. Blots were scanned using an Odyssey CLx infrared scanner (LI-
COR Biosciences, Lincoln, NE, USA) with IRDye LI-COR secondary antibodies (Table S1). 
The acquired images were analyzed and quantified with Image Studio 5.2.5 software (LI-COR). 
 
Coupled in vitro transcription and translation 
Reactions were performed in the TnT Quick Coupled Transcription/Translation System 
(Promega, Madison, WI, USA) on TRC40-immunodepleted reticulocyte lysate (using rabbit 























2010; Pfaff et al., 2016). First, 150 ng of pET23b_c-Myc-TRC40 variants were added to 4.5 
L of each lysate and incubated for 30 min at 30°C (reaction #1). In the meantime, 250 ng of 
pGEM3Z_Stx5-op were added to a second set of 4.5 L aliquoted lysates and kept on ice until 
use (reaction #2). Second, reactions #1 and #2 were combined and the transcription/translation 
was carried out for additional 90 minutes at 30°C. Third, the ER-integration assay was 
performed by adding 1 L of pancreatic rough microsomes (RM) to the reaction mix and 
incubating it for 90 min at 30°C. Finally, the assay was stopped with 30 L SDS-sample buffer 




Data are presented as mean±s.e.m. Statistical analysis was assessed via an unpaired parametric 
two-tailed Student’s t-test. To determine statistical significance (P<0.05) GraphPad Prism 6.0 
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Silencing WRB and TRC40 affects the steady-state levels of many TA-proteins. (A) 
Western blots demonstrating the down-regulation of TRC40 and WRB upon transfection with 
previously characterized siRNAs (Pfaff et al., 2016; Rivera-Monroy et al., 2016; Yamamoto 
and Sakisaka, 2012). (B) Quantifications of Western blots shown in A (n3, mean and s.e.m. 
shown). (C) Western blots of the membrane fraction to detect steady-state levels of different 
TA-proteins after silencing TRC40 or TRC40 and WRB. The line indicates that the two panels 
are derived from the same lanes of the same gel. All other panels have a pertinent loading 
control used for the quantification but not shown here. (D) Quantifications of Western blots 
shown in C (n3, mean and s.e.m. shown). Statistics were determined by two-tailed t-test. 

























Figure 2  
Over-expression of TRC40D74E leads to the mislocalization of Stx5.  (A) Model of the 
TRC40 ATPase cycle based on structures representing different intermediates in the ATPase 
cycle of yeast Get3. The Protein Data Bank (PDB) IDs used for this scheme are the following: 
3H84, 2WOJ, 4PWX, 2LPF, 4XTR, 3ZS9, 3SJB. (B) Stx5 insertion into canine microsomes 
was detected by the glycosylation of the C-terminal opsin tag. Opsin-tagged Stx5 was in-vitro 
translated in rabbit reticulocyte lysate, mock-depleted or TRC40-immunodepleted. In these 























of opsin-tagged Stx5. Western blot was performed detecting the indicated proteins. Below: 
Quantification of Stx5 glycosylation, percentage of total (n=4, mean and s.e.m. shown). 
Statistics were determined by two-tailed t-test. Asterisks depict statistical significance 
(***P<0.001). (C,D) Immunofluorescence analysis of the subcellular localization of TA-
proteins in HeLa cells over-expressing c-Myc-TRC40 variants. Transfection with the empty 
vector (EV) was used as negative control. Cells were fixed and stained for c-Myc-TRC40 



























In the presence of TRC40D74E Stx5 accumulates in the cytoplasm. (A) Experimental strategy 
testing whether Stx5 was washed out in TRC40D74E-transfected cells after treatment with 
digitonin. (B) Cells were semipermeabilized in the presence of a buffer containing 0.007% 
digitonin and then fixed. Cells were subjected to indirect immunofluorescence using antibodies 
against c-Myc (magenta) and Stx5 (green) (n=3). Dashed lines outline c-Myc-TRC40-
transfected cells. Scale bars: 20 m. (C) Stx5 accumulated in the cytosol of cells over-
expressing TRC40D74E. Cell lysates from the Stx5-opsin stable cell line were subjected to 
fractionation. Cells were transfected with either c-Myc-TRC40 or c-Myc-TRC40D74E. 
Transfection with the empty vector (EV) was used as negative control. Subsequently, the 
expression of Stx5-opsin was induced with 1 g/mL of tetracycline (Tet) for 6 h. Western blot 























cytosol in the absence of detergent shows that TRC40D74E interacts with TA-proteins such as 
Stx5 and Sec61. Cells were transfected with c-Myc-TRC40 variants using the empty vector 
(EV) as negative control. Western blot was performed detecting the indicated proteins. Note 
that endogenous Stx5 migrates as two different bands due to alternative start codons (Hui et al., 






































Unbiased SWATH mass spectrometry analysis reveals additional TA-substrates. 
TRC40D74E TA-protein enrichment compared to the mutant manipulating the TA-binding 
groove, TRC40D74E/L190D/I193D. Volcano-plot for c-Myc-TRC40 SWATH-based interactome 
(n=3). TRC pathway components are labelled in magenta, TA-proteins in blue. The dotted line 




























TA-golgins are trapped by TRC40D74E. (A) HeLa cells were transfected to express c-Myc-
TRC40 constructs and later processed for indirect immunofluorescence using antibodies against 
c-Myc (magenta) and giantin (green) (n=3). Transfection with the empty vector (EV) was used 
as negative control. Scale bars: 20 m. (B) Comparison of TMS of the TA-golgins. (C) Co-
immunoprecipitation from cytosol in the absence of detergent shows that TRC40D74E interacts 























variants using the empty vector (EV) as negative control. Western blot was performed detecting 
the indicated proteins. (D) Quantifications of Western blots shown in C (n=4, mean and s.e.m. 
shown). Statistics were determined by two-tailed t-test. Asterisks indicate statistical 



















































TMS hydrophobicity determines but does not fully explain TRC40-dependence. (A) 
Summary of the trapping efficiency observed for different TA-proteins with c-Myc-TRC40D74E 
as compared to wild type c-Myc-TRC40 (n3, mean and s.e.m. shown) plotted against the 
hydrophobicity score of the TMS (GRAVY) (Kyte and Doolittle, 1982). (B) Effects of 
combined siRNA-mediated down-regulation of TRC40 and WRB on the depicted TA-proteins 























to the GRAVY scale.  Statistics were determined by two-tailed t-test. Asterisks depict statistical 
significance (*P<0.05; **P<0.01; ***P<0.001). Giantin is depicted with a dashed symbol on 
top of the scheme to indicate its TMS hydrophobicity score similar to the other two TA-golgins. 
The dotted line (x axes) indicates the hydrophobicity score of Sec61 TMS and (y axes) the 
same ratio of TA-protein normalized to the pertinent control. TA-proteins that were not trapped 

























TRC40-dependence of TA-protein targeting. Based on the interaction with TRC40D74E and 
the steady-state levels when the TRC pathway is impaired (Figs 1,4,5,6,S2,S3,S4,S6,S7), TA-
proteins can be categorized in the following groups: (1) Substrates can interact with TRC40D74E 
and they are affected at the steady-state when the pathway is downregulated. Therefore, TRC40 
is likely involved in the targeting of those proteins. (2) These TA-proteins can interact with 
TRC40D74E but they remain unaltered upon the knockdown of the pathway. Even though they 
can interact with TRC40, there is redundancy and robust targeting in the absence of the TRC 
pathway. (3) Despite of the lack of interaction with TRC40, the combined knockdown of WRB 
and TRC40 affects the steady-state levels of this group of TA-proteins. Hence, the decrease of 
their protein steady-state levels most likely reflects an indirect effect. (4) Other pathways target 
these TA-proteins that are unable to interact with TRC40 and their steady-state levels are 






























Vesicle transport through interaction with t-
SNAREs homolog 1A 
3.132 5.464 6.7295E-06 
STX6 Syntaxin-6 3.237 7.211 8.5147E-05 
GOSR2 Golgi SNAP receptor complex member 2 2.168 2.918 2.70E-04 
SEC22B Vesicle-trafficking protein SEC22b 2.184 5.382 4.71E-04 
SEC20 Vesicle transport protein SEC20 isoform BNIP1 2.584 7.899 4.76E-04 
GOLGIN-84 Golgin subfamily A member 5 2.087 12.568 3.03E-04 
STX3 Syntaxin-3 3.448 19.717 1.21E-04 
SEC61B Protein transport protein Sec61 subunit beta 2.048 5.016 1.21E-03 
STX18 Syntaxin-18 1.617 2.672 1.25E-03 
VAMP7 Vesicle-associated membrane protein 7 isoform 1 2.575 21.021 1.63E-03 
CASP Protein CASP 2.000 4.699 1.80E-03 
STX5 Syntaxin-5 3.105 2.625 0.002 
VAPA 
Vesicle-associated membrane protein-associated 
protein A 
2.479 12.732 0.002 
EMD Emerin 2.553 13.165 0.002 
UBE2J1 Ubiquitin-conjugating enzyme E2, J1 2.558 7.246 0.002 
LAP2B Lamina-associated polypeptide 2, isoform beta 2.816 7.304 0.004 
STX4 Syntaxin-4 3.087 4.136 0.006 
VTI1B 
Vesicle transport through interaction with t-
SNAREs 1B 
2.104 1.551 0.006 
STX12 Syntaxin-12 3.104 8.390 0.013 
STX8 Syntaxin-8 2.726 3.125 0.013 
VAPB 
Vesicle-associated membrane protein-associated 
protein B/C 
2.868 6.590 0.028 
STX1A Syntaxin-1A 2.782 1.149 0.154 
BNIP3L BCL2/adenovirus E1B 19kD-interacting protein 3-
like 
























Identification of selected TA-proteins in TRC40D74E immunoprecipitates. The presence of 
candidate TA-proteins was assessed by Western blotting based on the availability of antibodies 
(compare Table S1). The TMS hydrophobicity score was calculated according to the GRAVY 
scale. Statistical significance was determined by two-tailed t-test. 
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Figure S1. In the presence of TRC40D74N Stx5 accumulates in cytoplasm. 
HeLa cells were transfected to express c-Myc-TRC40 constructs and later processed for 
indirect immunofluorescence using antibodies against TRC40 (magenta) and Stx5 
(green). Transfection with the empty vector (EV) was used as negative control. The signal 
observed from endogenous TRC40 was close to background and it is therefore not visible 
with the settings used. Three independent biological replicates were analyzed. Scale bars: 
20 µm. 

















































Figure S2. TRC40D74E traps EMD in the cytoplasm. 
HeLa cells were transfected to express c-Myc-TRC40 constructs. Cells were subjected to 
indirect immunofluorescence using antibodies against c-Myc (magenta) and Stx5 (green). 
Three independent biological replicates were analyzed. Scale bars: 20 µm. 


















































Figure S3. A double mutation in the TA-binding groove of TRC40D74E partially 
restores Stx5 localization. 
HeLa cells were transfected to express c-Myc-TRC40 constructs. Cells were subjected to 
indirect immunofluorescence using antibodies against c-Myc (magenta), the cis-Golgi 
marker GM130 (yellow) and Stx5 (green). Three independent biological replicates were 
analyzed. Scale bars: 20 µm. 

























Figure S4. Candidate testing reveals many TA proteins interacting with the TRC40 
trap mutant via the TA-binding groove. 
(A-B) Co-immunoprecipitation from cytosol in the absence of detergent shows that 
TRC40D74E interacts with many TA-proteins.  Cells were transfected with either 
c-Myc-TRC40, c-Myc-TRC40D74E or c-Myc-TRC40D74E/L190D/I193D using the empty vector (EV) 
as negative control. Western blot was performed detecting the indicated proteins. Three 
independent biological replicates were analyzed. The line indicates that the two panels are 
derived from the same lanes of the same gel. All other panels have a pertinent bait control 
used for the quantification but not shown here.(C) Detection of PTP1B, Fis1, ZFPL1, 
MAVS, MOSPD2, Nesprin-1 alpha 2 isoform and Nesprin-3 in the co-immunoprecipitated 
material reveals their absence from the c-Myc immuno-precipitates. Whole cell lysate 
(WCL) indicates the presence of the proteins in the transfected cells. The line indicates 
that the two panels are derived from the same lanes of the same gel. All other panels have 
a pertinent bait control used for the quantification but not shown here.

























Figure S5. Quantitative SWATH mass spectrometry confirms TA-binding groove 
dependent enrichment of Stx5 with TRC40D74E. 
(A) Representative Western blots of eluates from anti-c-Myc-immunoprecipitation detect-
ing the immunoprecipitated TRC40 variants and the co-precipitating TA protein Stx5. Note 
that endogenous Stx5 migrates as two different bands due to alternative start codons (Hui 
et al., 1997). At least three independent biological replicates were analyzed. (B) Quantifi-
cation of c-Myc signal in immunoprecipitated material. The graph shows the mean and the 
error bars depict +-s.e.m.. Statistics were determined by two-tailed Student’s t-test. Aster-
isks indicate statistical significance (*** P < 0.001). (C) Quantification of ratio between 
co-immunoprecipitated Stx5 and TRC40 variants. The graph shows the mean and the 
error bars depict +-s.e.m.. Statistics were determined by two-tailed Student’s t-test. Aster-
isks indicate statistical significance (*** P < 0.001). (D) Peptide-based quantification of 
TRC40 variants from SWATH mass spectrometry analysis. Three independent biological 
replicates were analyzed. The graph shows the mean and the error bars depict +-s.e.m. 
(E) Quantification of ratio between co-immunoprecipitated Stx5 and TRC40 variants as 
obtained by SWATH mass spectrometry analysis. The graph shows the mean and the 
error bars depict +-s.e.m.. Statistics were determined by two-tailed Student’s t-test. Aster-
isks indicate statistical significance (* P < 0.05; ** P < 0.01).
























































Figure S6. Stx6 and Stx8 are partially mislocalized upon over-expression of the 
TRC40 trap. 
(A-B) HeLa cells were transfected to express c-Myc-TRC40 constructs and later 
processed for indirect immunofluorescence using antibodies against c-Myc (magenta), 
Stx6 (green, A) and Stx8 (green, B). Transfection with the empty vector (EV) was used as 
negative control. Three independent biological replicates were analyzed. Scale bars: 20 
µm. 






























































































Figure S7. Silencing WRB and TRC40 affects the steady-state levels of many TA pro-
teins. 
(A) Exemplary Western blots of the steady-state levels of different TA proteins after silenc-
ing TRC40 or TRC40 and WRB. The line indicates that the two panels are derived from the 
same lanes of the same gel. All other panels have a pertinent loading control used for the 
quantification but not shown here. (B) Quantifications of Western blots shown in A. All 
experiments were performed at least in biological triplicates. The plots depict the mean +- 
s.e.m.. Statistics were determined by two-tailed Student’s t-test. Asterisks depict statistical 
significance (* P <  0.05; ** P <  0.01; *** P < 0.001). The dotted line indicates the siLuc 
steady-state levels.
































































Relative to Na/K ATPase
34 Stx1A
Stx1A





















Relative to Na/K ATPase

























Table S1. List of primary and secondary antibodies used in this study. 
Name Raised in Company Catalog no. Lot # Dilution (WB) 
Dilution 
(IF) 
BNIP3L mouse Invitrogen 39-3300 QC215886 1:250 
CAML guinea pig Synaptic Systems 359 004 359004/1 1:1000 
CASP rabbit Proteintech 11733-1-AP 50220 1:1000 
Emerin rabbit Santa Cruz sc-15378 H1115 1:1000 1:150 
Fis1 rabbit Thermo Fisher PA1-41082 QC1999106 1:1000 
GAPDH mouse NeoBiotech NB-29-00852 16/06-G4-C5 1:40000 
Giantin guinea pig Synaptic Systems 263005 263005/1 1:200 
GM130 mouse BD Transduction Laboratories 610823 24277 1:300 
Golgin-84 rabbit Sigma-Aldrich HPA000992 A104695 1:1000 
GOSR2 rabbit Synaptic Systems 170003 170003/4 1:1000 
Lamin-A/C mouse abcam ab40567 1:200 
LAP2B rabbit Sigma-Aldrich SAB2102484 QC14874 1:1500 
MAVS mouse Santa Cruz sc-166583 L0417 1:500 
MOSPD2 rabbit abcam ab129250 GR89338-4 1:500 
c-Myc mouse Santa Cruz sc-40 B0116 1:1000 1:200 
c-Myc rabbit Santa Cruz sc-789 I171 1:200 
Na+/K+-ATPase 
α1 mouse Santa Cruz sc-21712 B1516 1:1000 
Nesprin-1 rabbit abcam ab192234 GR181158-5 1:1000 
Nesprin-3 rabbit abcam ab186751 GR163090-1 1:1000 
Opsin mouse From Bernhard Dobberstein 1:1000 
PTP1B rabbit Sigma-Aldrich HPA012542 1:1000 1:100 
SEC20 rabbit abcam ab151551 YJ081322CS 1:1000 
Sec22b rabbit Synaptic Systems 186003 186003/1-8 1:1000 
Sec61β rabbit From Bernhard Dobberstein 1:1000 1:300 
Squalene synthase mouse Santa Cruz sc-271602 D2816 1:1000 
Syntaxin 1 mouse Synaptic Systems 110011 110011/13 1:1000 
Syntaxin 3 rabbit Synaptic Systems 110033 110033/24 1:750 
Syntaxin 4 rabbit Synaptic Systems 110041 110041/2 1:1000 
Syntaxin 5 rabbit Synaptic Systems 110053 110053/16 1:2000 1:250 
Syntaxin 6 rabbit Synaptic Systems 110062 110062/9 1:1000 1:300 
Syntaxin 8 rabbit Synaptic Systems 110083 110083/1-11 1:1000 1:300 
Syntaxin 12 rabbit Synaptic Systems 110133 110133/2 1:1000 

























Syntaxin 18 rabbit Synaptic Systems 110183 110183/3 1:1000 
TRC40 mouse Sigma-Aldrich WH0000439M3 D3011-2H3 1:1000 1:100 
TRC40 rabbit Proteintech 15450-1-AP 00021130 1:1000 
TRC40 #4 rabbit From Bernhard Dobberstein 1:1000 
UBE2J1 mouse Santa Cruz sc-377002 H2917 1:1000 
USE1 rabbit Proteintech 25218-1-AP 00022214 1:1000 
VAMP7 rabbit Synaptic Systems 232003 232003/2-9 1:1000 
VAPA rabbit Proteintech 15275-1-AP 00022782 1:1000 
VAPB rabbit Proteintech 14477-1-AP 00013727 1:1000 
Vti1a rabbit Synaptic Systems 165003 165003/1 1:1000 
Vti1b rabbit Synaptic Systems 164002 164002/7 1:1000 
WRB rabbit Synaptic Systems 324002 324002/1-2 1:500 
ZFPL1 rabbit Sigma-Aldrich HPA014909 A117095 1:1000 
Short Name Conjugated to Company Catalog no. Lot # Dilution 
α-mouse HRP HRP Santa Cruz sc-516102 F2017 1:10000 
α-rabbit 800 IRDye 800CW LI-COR 926-32213 1:5000 
α-rabbit 680 IRDye 680LT LI-COR 926-68023 1:5000 
α-mouse 800 IRDye 800CW LI-COR 926-32212 1:5000 
α-mouse 680 IRDye 680LT LI-COR 926-68050 1:5000 
α-guinea pig 680 IRDye 680LT LI-COR 926-32421 1:5000 
α-guinea pig 488 Alexa Fluor 488 Invitrogen A11073 1458631 1:1000 
α-rabbit 488 Alexa Fluor Plus 488 Invitrogen A32731 SE250296 1:1000 
α-mouse 546 Alexa Fluor 546 Invitrogen A11030 1829584 1:1000 
α-mouse 647 Alexa Fluor 647 Invitrogen A21235 1511346 1:1000 
α-mouse 647 Alexa Fluor Plus 647 Invitrogen A32728 SE250294 1:1000 

























Table S2. TA-proteins pulled-down with the c-Myc-TRC40D74E construct analysed by mass-
spectrometry.  




Vesicle-associated membrane protein-associated 
protein B/C 
VAPB 0.0002 1.2995493 
EMD_HUMAN Emerin EMD 0.0007 1.2408614 
VAMP7_HUMAN Vesicle-associated membrane protein 7 VAMP7 0.0008 2.3780926 
GOGB1_HUMAN Golgin subfamily B member 1 (Giantin) GOLGB1 0.0035 -1.7250403 
LAP2B_HUMAN 
Lamina-associated polypeptide 2, isoforms 
beta/gamma 
LAP2 0.0057 0.5583429 
K7ESP4_HUMAN Dephospho-CoA kinase domain-containing protein DCAKD 0.0220 1.1499333 
UB2J1_HUMAN Ubiquitin-conjugating enzyme E2 J1 UBE2J1 0.0241 1.3633126 




CDKAL1 0.0753 0.8713599 
MAVS_HUMAN Mitochondrial antiviral-signaling protein (MAVS) MAVS 0.2301 0.5362815 
INP4A_HUMAN Type I inositol 3,4-bisphosphate 4-phosphatase INPP4A 0.5117 0.363725 
MCL1_HUMAN 
Induced myeloid leukemia cell differentiation protein 
Mcl-1 
MCL1 0.5297 0.7643984 
E7EST9_HUMAN Ubiquitin carboxyl-terminal hydrolase 19 USP19 0.5301 0.6081325 
Q96NX8_HUMAN Syntaxin-16D STX16 0.5515 0.408667 
LRC59_HUMAN Leucine-rich repeat-containing protein 59 LRRC59 0.6505 0.3805235 
FA98B_HUMAN Protein FAM98B FAM98B 0.8603 0.180839 
FIS1_HUMAN Mitochondrial fission 1 protein FIS1 0.8610 -0.0717239 
GOGA5_HUMAN Golgin subfamily A member 5 (Golgin-84) GOLGA5 0.9002 0.0384847 

























Table S3. Peptides obtained in MS and used for quantitation of statistically significant TA-proteins 


























17.72 17.74 51.8 11 TVQSNSPISALAPTGK 201-216 
VEQVLSLEPQHELK 4-17 
P50402 Emerin EMD 
DSAYQSITHYRPVSASR 158-174 














































DCAKD INAQLPLTDK 159-168 2.07 2.08 10.5 1 
Q13190 Syntaxin-5 STX5 
APVSALPLAPNHLGGGAVVLGAESHASK 214-241 














72.13 72.31 22.6 34 GLTAQIQSFGR 2728-2738 
SAAQPSTSPAEVQSLKK 2865-2881 
Unused Score: Sum of -log (confidence) values of all peptides per protein which is not claimed by other, 
non-overlapping hypotheses. 
Total Score: Sum of -log (confidence) values of all peptides per protein. 
PSMs >95%: number of primary sequences per protein substantiated by >95% confidence matches 
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